ReviewTherapeutic advances in gastroenterology2018

Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?

Marc Bourlière et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.